Back to search

Netherlands· NL-bc503238cc44

Theranal aambeienzalf, zalf voor rectaal gebruik

A lidocaine product containing bismutsubnitraat + lidocaïne + zinkoxide, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC C05AD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTheranal aambeienzalf, zalf voor rect…ATCC05AD01REGISTER NO.NL-bc503238cc44PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lidocaine is registered in 10 of 19 countries.

Countries holding a registration under ATC C05AD01 (lidocaine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Lidocaine · ATC C05AD01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BISMUTSUBNITRAAT + LIDOCAÏNE + ZINKOXIDE
Manufacturer
Bayer B.V.
Country
Netherlands (NL)
ATC code
C05AD01
ATC class
Lidocaine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    01110

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for lidocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lidocaine · interactions on record

39 records

  • 1 severe
  • 38 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/63dd0f6e-a8a8-4f2d-bdbe-3c0bac1fb56d
GET /v1/drugs/63dd0f6e-a8a8-4f2d-bdbe-3c0bac1fb56d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zalf voor rectaal gebruik",
  "route": "Rectaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h01110_smpc.pdf",
  "strength": null,
  "atc_label": "Lidocaine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg01110",
  "excipients": [
    "ALCLOXA",
    "CETYLALCOHOL",
    "PARAFFINE, VLOEIBAAR (E905)",
    "PARAFFINE, ZACHT (E 905)",
    "THYMOL",
    "WOLVET"
  ],
  "substances": [
    "BISMUTSUBNITRAAT",
    "LIDOCAÏNE",
    "ZINKOXIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h01110.pdf",
  "authorised_at": "1973/08/15",
  "procedure_number": null,
  "dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 23 september 2021]",
  "registration_number": "01110",
  "additional_monitoring": "N"
}

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.